您的位置: 首页 > 农业专利 > 详情页

The cyclopropanecarboxylcompound of purine analogue
专利权人:
ANNJI PHARMACEUTICAL CO. LTD.
发明人:
申请号:
IL23509714
公开号:
IL235097A
申请日:
2014.10.19
申请国别(地区):
IL
年份:
2017
代理人:
摘要:
The invention discloses the cyclopropanecarboxylcompound of purine analogue, preparation method and it is used for treatment herpesvirus infection and tumour. In one embodiment of the invention, the compound of the present invention can be used for treating cancer. Cancer patient can apply a kind of carrier before applying the compound of the present invention first, it may for example comprise the adenovirus vector of the DNA fragmentation of coding HSV thymidine kinases, the carrier express HSV thymidine kinases in the tumour cell of subject. On the other hand, the purposes the present invention relates to compound above-mentioned, its pharmaceutically acceptable salt, solvate, hydrate, pro-drug or metabolite in the drug of preparation treatment herpesvirus infection. The drug can be used for treating herpes simplex viral infections, herpes zoster infection or cytomegalovirus infection.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充